Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Danilenko, M, Stamp, E, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (15 more authors) (2018) Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial. JAMA dermatology, 154 (8). pp. 913-921. ISSN 2168-6068

Cranston, A, Stocken, DD orcid.org/0000-0001-8031-1738, Stamp, E et al. (7 more authors) (2017) Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial. Trials, 18. 111. ISSN 1745-6215

Vickers, RJ, Tillotson, GS, Nathan, R et al. (41 more authors) (2017) Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. The Lancet Infectious Diseases, 17 (7). pp. 735-744. ISSN 1473-3099

This list was generated on Sun Aug 18 21:00:38 2019 BST.